← Open Payments lookup

ROBERTO PARRA: Open Payments

NPI 1841068384 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 36 payments from 10 companies in 2025. Trend: 2023 $106 · 2024 $1,216 · 2025 $781

Food & beverage: $781
CompanyPaymentsAmount
Axsome Therapeutics, Inc.8$185
ABBVIE INC.12$180
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$156
E.R. Squibb & Sons, L.L.C.3$74
Tris Pharma Inc1$40
Vanda Pharmaceuticals Inc.2$39
Teva Pharmaceuticals USA, Inc.2$37
Lundbeck LLC2$34
Alkermes, Inc.1$20
Neurocrine BioSciences, Inc.1$16

Products named: Auvelity, VRAYLAR, CAPLYTA, COBENFY, Dyanavel XR, FANAPT, AUSTEDO XR, REXULTI.

Industry payments across TX — which companies pay providers there.